KVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source
KVK-Tech, Inc. is recalling 14,664 bottles of Hydroxyzine Hydrochloride 10 mg tablets because the active ingredient came from an unapproved source.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source text does not report any illnesses, injuries, or fatalities, and the hazard is related to manufacturing compliance (unapproved source) rather than a confirmed toxicological event, fitting the 'Moderate' criteria for low-risk contamination or voluntary precautionary measures.
Plain-English summary
KVK-Tech, Inc. is recalling 14,664 bottles of Hydroxyzine Hydrochloride 10 mg tablets (NDC #10702-010-01). The affected product is Lot #11434, with an expiration date of November 2014. The bottles contain 100 tablets each and are prescription-only.
The recall was initiated due to Good Manufacturing Practices deviations. Specifically, the product contains an Active Pharmaceutical Ingredient (API) from an unapproved source. This issue was identified by the U.S. Food and Drug Administration.
The affected product was distributed nationwide, including Puerto Rico, to wholesale distributors for sale to retail establishments. Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should be returned to the pharmacy or point of purchase for disposal or credit, as directed by the recalling firm.
The recalled product
- Product
- HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)
- Brand
- HYDROXYZINE HYDROCHLORIDE
- Manufacturer
- KVK-Tech, Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 14,664
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- lot #11434
- exp. Nov-14
UPCs (1)
- 0310702012103
Distribution
Part of a larger recall action
This product is one of 3 recalled by KVK-Tech, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · HYDROXYZINE HYDROCHLORIDE
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateLannett Recalls Hydroxyzine Hydrochloride Syrup Due to Impurities
FDA (Drugs) · 2018-10-31
- SevereKVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source
FDA (Drugs) · 2014-01-29
- ModerateKVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source
FDA (Drugs) · 2014-01-29
Same manufacturer · KVK-Tech, Inc.
See all →- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- SevereAtovaquone Oral Suspension Recalled for Temperature Abuse
FDA (Drugs) · 2021-09-01
- ModerateKVK-Tech Recalls Hydrocodone and Homatropine Tablets for Impurity Failures
FDA (Drugs) · 2021-05-26
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11